Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Barroilhet

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2022
Opportunistic osteoporosis screening using routine computed tomography images to identify bone loss in gynecologic cancer survivorsJanelle Sobecki, Benjamin Weigman, India Anderson-Carter, et al.
Magnetic Resonance Imaging Clinics of North America|July 3, 2017
MR Imaging of Cervical CancerKrupa Patel-Lippmann, Jessica B Robbins, Lisa Barroilhet, et al.
Scientific Reports|August 9, 2019
Plumbagin-induced oxidative stress leads to inhibition of Na<sup>+</sup>/K<sup>+</sup>-ATPase (NKA) in canine cancer cellsYousef Alharbi, Arvinder Kapur, Mildred Felder, et al.
The American Journal of Case Reports|May 21, 2017
KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation SequencingDaniel R Matson, Jin Xu, Laura Huffman, et al.
Journal of Cheminformatics|October 7, 2024
Data mining of PubChem bioassay records reveals diverse OXPHOS inhibitory chemotypes as potential therapeutic agents against ovarian cancerSejal Sharma, Liping Feng, Nicha Boonpattrawong, et al.
Gynecologic Oncology|September 25, 2010
Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatmentVictoria L Bae-Jump, Chunxiao Zhou, John F Boggess, et al.
Cancer|November 21, 2014
Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2Patricia M Jamison, Sean F Altekruse, Joanne T Chang, et al.
Journal of Minimally Invasive Gynecology|November 13, 2015
The Feasibility and Safety of Adopting Single-Incision Laparoscopic Surgery into Gynecologic Oncology PracticeAshley J Jennings, Ryan J Spencer, Laura Hanks, et al.
Radiology|May 1, 2019
<i>BRCA</i> Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging ConsiderationsMai Elezaby, Brittany Lees, Katherine E Maturen, et al.
The Journal of Investigative Dermatology|March 25, 2026
Atovaquone-induced therapeutic rewiring of melanoma metabolismMayra Betancourt Ponce, Alexa R Heaton, Samantha K Burkard, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2022
Opportunistic osteoporosis screening using routine computed tomography images to identify bone loss in gynecologic cancer survivorsJanelle Sobecki, Benjamin Weigman, India Anderson-Carter, et al.
Magnetic Resonance Imaging Clinics of North America|July 3, 2017
MR Imaging of Cervical CancerKrupa Patel-Lippmann, Jessica B Robbins, Lisa Barroilhet, et al.
Scientific Reports|August 9, 2019
Plumbagin-induced oxidative stress leads to inhibition of Na<sup>+</sup>/K<sup>+</sup>-ATPase (NKA) in canine cancer cellsYousef Alharbi, Arvinder Kapur, Mildred Felder, et al.
The American Journal of Case Reports|May 21, 2017
KRAS and GNAS Co-Mutation in Metastatic Low-Grade Appendiceal Mucinous Neoplasm (LAMN) to the Ovaries: A Practical Role for Next-Generation SequencingDaniel R Matson, Jin Xu, Laura Huffman, et al.
Journal of Cheminformatics|October 7, 2024
Data mining of PubChem bioassay records reveals diverse OXPHOS inhibitory chemotypes as potential therapeutic agents against ovarian cancerSejal Sharma, Liping Feng, Nicha Boonpattrawong, et al.
Gynecologic Oncology|September 25, 2010
Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatmentVictoria L Bae-Jump, Chunxiao Zhou, John F Boggess, et al.
Cancer|November 21, 2014
Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2Patricia M Jamison, Sean F Altekruse, Joanne T Chang, et al.
Journal of Minimally Invasive Gynecology|November 13, 2015
The Feasibility and Safety of Adopting Single-Incision Laparoscopic Surgery into Gynecologic Oncology PracticeAshley J Jennings, Ryan J Spencer, Laura Hanks, et al.
Radiology|May 1, 2019
<i>BRCA</i> Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging ConsiderationsMai Elezaby, Brittany Lees, Katherine E Maturen, et al.
The Journal of Investigative Dermatology|March 25, 2026
Atovaquone-induced therapeutic rewiring of melanoma metabolismMayra Betancourt Ponce, Alexa R Heaton, Samantha K Burkard, et al.
Pageof 6